News for Healthier Living

Multi-Omics Joint Analysis Revealed the Metabolic Profile of Retroperitoneal Liposarcoma

This paper reveals the metabolic profile of retroperitoneal liposarcoma via proteomic, metabolomic, and lipidomic analyses, showing upregulated glycolysis and downregulated TCA cycle, and finds that glycolytic and PPP inhibitors enhance MDM2 and CDK4 inhibitors' antitumor effects, suggesting therapeutic strategies.

October 31, 2025


October 31 2025

October 30 2025

October 29 2025

October 28 2025

October 27 2025

October 26 2025

October 25 2025

October 24 2025

October 23 2025

October 22 2025

October 21 2025

October 20 2025

October 19 2025

October 18 2025

October 17 2025